Open AccessMultisystem Inflammatory Syndrome in Infants <12 months of Age, United States, May 2020–January 2021
Author(s) -
Shana GodfredCato,
Clarisse A. Tsang,
Jennifer Giovanni,
Joseph Y. Abrams,
Matthew E. Oster,
Ellen H. Lee,
Maura K. Lash,
Chloe Le Marchand,
Caterina Y. Liu,
Caitlin N Newhouse,
Gillian Richardson,
Meghan Murray,
Sarah Lim,
Thomas Haupt,
Amanda Hartley,
Lynn Sosa,
Kompan Ngamsnga,
Ali Garcia,
Deblina Datta,
Ermias D. Belay
Publication year - 2021
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003149
Subject(s) - medicine , rash , pediatrics , pneumonia , vomiting , diarrhea , vital signs , surgery
Multisystem inflammatory syndrome in children (MIS-C), temporally associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been identified in infants <12 months old. Clinical characteristics and follow-up data of MIS-C in infants have not been well described. We sought to describe the clinical course, laboratory findings, therapeutics and outcomes among infants diagnosed with MIS-C.